• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有证据表明DNA拓扑异构酶I是喜树碱产生细胞毒性作用所必需的。

Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin.

作者信息

Eng W K, Faucette L, Johnson R K, Sternglanz R

机构信息

Department of Biochemistry, State University of New York, Stony Brook 11794.

出版信息

Mol Pharmacol. 1988 Dec;34(6):755-60.

PMID:2849043
Abstract

The budding yeast Saccharomyces cerevisiae and the fission yeast Schizosaccharomyces pombe are both sensitive to camptothecin, an inhibitor of DNA topoisomerase I. An S. cerevisiae DNA repair mutant, rad52, is hypersensitive to the drug. In both species, topoisomerase I mutants totally lacking the enzyme are completely resistant to the drug. A strain with a mutation leading to a temperature-sensitive topoisomerase I exhibits temperature dependence in its in vivo response to camptothecin. A strain carrying a plasmid that overproduces topoisomerase I is hypersensitive to the drug. The rad52 mutant is killed by overproduction of the enzyme, even in the absence of the drug. The response of several of these strains to camptothecin analogs, to DNA topoisomerase II inhibitors, and to other drugs is reported. The cytotoxic effects of camptothecin are discussed in terms of the drug extending the lifetime of a topoisomerase I-DNA covalent intermediate, which is recognized as DNA damage by a DNA repair system.

摘要

出芽酵母酿酒酵母和裂殖酵母粟酒裂殖酵母对喜树碱(一种DNA拓扑异构酶I抑制剂)均敏感。酿酒酵母的一个DNA修复突变体rad52对该药物高度敏感。在这两个物种中,完全缺乏该酶的拓扑异构酶I突变体对该药物完全耐药。一个因突变导致拓扑异构酶I温度敏感的菌株在其对喜树碱的体内反应中表现出温度依赖性。携带过量表达拓扑异构酶I质粒的菌株对该药物高度敏感。即使在没有药物的情况下,rad52突变体也会因该酶的过量表达而死亡。报道了其中几种菌株对喜树碱类似物、DNA拓扑异构酶II抑制剂和其他药物的反应。从药物延长拓扑异构酶I-DNA共价中间体寿命的角度讨论了喜树碱的细胞毒性作用,该中间体被DNA修复系统识别为DNA损伤。

相似文献

1
Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin.有证据表明DNA拓扑异构酶I是喜树碱产生细胞毒性作用所必需的。
Mol Pharmacol. 1988 Dec;34(6):755-60.
2
A temperature sensitive topoisomerase II allele confers temperature dependent drug resistance on amsacrine and etoposide: a genetic system for determining the targets of topoisomerase II inhibitors.一种温度敏感的拓扑异构酶II等位基因赋予安吖啶和依托泊苷温度依赖性耐药性:一种用于确定拓扑异构酶II抑制剂靶点的遗传系统。
Cancer Res. 1993 Jan 1;53(1):89-93.
3
Camptothecin resistance from a single mutation changing glycine 363 of human DNA topoisomerase I to cysteine.人DNA拓扑异构酶I的甘氨酸363突变为半胱氨酸导致的喜树碱耐药性。
Cancer Res. 1993 Sep 15;53(18):4343-8.
4
Expression of human DNA topoisomerase I in yeast cells lacking yeast DNA topoisomerase I: restoration of sensitivity of the cells to the antitumor drug camptothecin.人DNA拓扑异构酶I在缺乏酵母DNA拓扑异构酶I的酵母细胞中的表达:恢复细胞对抗肿瘤药物喜树碱的敏感性。
Cancer Res. 1989 Nov 15;49(22):6318-23.
5
Differential expression of topoisomerase I and RAD52 protein in yeast reveals new facets of the mechanism of action of bisdioxopiperazine compounds.拓扑异构酶I和RAD52蛋白在酵母中的差异表达揭示了双二氧哌嗪化合物作用机制的新方面。
Br J Cancer. 1999 Nov;81(5):800-7. doi: 10.1038/sj.bjc.6690767.
6
Camptothecin-resistant mutants of Chinese hamster ovary cells containing a resistant form of topoisomerase I.含有拓扑异构酶I抗性形式的中国仓鼠卵巢细胞喜树碱抗性突变体。
Cancer Res. 1988 Nov 15;48(22):6404-10.
7
DNA topoisomerase II is the molecular target of bisdioxopiperazine derivatives ICRF-159 and ICRF-193 in Saccharomyces cerevisiae.DNA拓扑异构酶II是双二氧哌嗪衍生物ICRF - 159和ICRF - 193在酿酒酵母中的分子靶点。
Cancer Res. 1995 Jun 1;55(11):2299-303.
8
Analysis of yeast DNA topoisomerase II mutants resistant to the antitumor drug amsacrine.对耐抗肿瘤药物安吖啶的酵母DNA拓扑异构酶II突变体的分析。
Cancer Res. 1994 Apr 1;54(7):1795-800.
9
Repair of topoisomerase I covalent complexes in the absence of the tyrosyl-DNA phosphodiesterase Tdp1.在缺乏酪氨酰-DNA磷酸二酯酶Tdp1的情况下修复拓扑异构酶I共价复合物。
Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14970-5. doi: 10.1073/pnas.182557199. Epub 2002 Oct 23.
10
Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.E2F-1/DP-1转录因子复合物过表达后拓扑异构酶I和II抗癌药物的差异细胞毒性途径
Clin Cancer Res. 2000 Apr;6(4):1488-97.

引用本文的文献

1
Camptothecin, a topoisomerase I inhibitor, impedes productive herpes simplex virus type 1 infection.喜树碱是一种拓扑异构酶I抑制剂,可阻碍单纯疱疹病毒1型的有效感染。
J Virol. 2025 Aug 28:e0127625. doi: 10.1128/jvi.01276-25.
2
Synthesis and investigation of thieno[2,3-]pyridines that restore activity of topotecan.恢复拓扑替康活性的噻吩并[2,3 - ]吡啶的合成与研究
RSC Med Chem. 2025 Jul 3. doi: 10.1039/d5md00509d.
3
TDP1 splice-site mutation causes HAP1 cell hypersensitivity to topoisomerase I inhibition.TDP1剪接位点突变导致HAP1细胞对拓扑异构酶I抑制作用高度敏感。
Nucleic Acids Res. 2025 Jan 11;53(2). doi: 10.1093/nar/gkae1163.
4
Computational screening and molecular docking of compounds from Traditional Chinese Medicine (TCM) by targeting DNA topoisomerase I to design potential anticancer drugs.基于 DNA 拓扑异构酶 I 的靶点,运用计算筛选和中药(TCM)化合物的分子对接,设计潜在的抗癌药物。
PLoS One. 2024 Sep 12;19(9):e0310364. doi: 10.1371/journal.pone.0310364. eCollection 2024.
5
Endophytic fungi: A future prospect for breast cancer therapeutics and drug development.内生真菌:乳腺癌治疗与药物开发的未来前景
Heliyon. 2024 Jul 4;10(13):e33995. doi: 10.1016/j.heliyon.2024.e33995. eCollection 2024 Jul 15.
6
Anthocyanin-Rich Berry Extracts Affect SN-38-Induced Response: A Comparison of Non-Tumorigenic HCEC-1CT and HCT116 Colon Carcinoma Cells.富含花青素的浆果提取物影响SN-38诱导的反应:非致瘤性HCEC-1CT和HCT116结肠癌细胞的比较。
Antioxidants (Basel). 2024 Jul 15;13(7):846. doi: 10.3390/antiox13070846.
7
Screening for cold tolerance genes in C. elegans, whose expressions are affected by anticancer drugs camptothecin and leptomycin B.筛选 C. elegans 中的耐寒基因,其表达受抗癌药物喜树碱和莱普霉素 B 的影响。
Sci Rep. 2024 Mar 5;14(1):5401. doi: 10.1038/s41598-024-55794-z.
8
Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates.ZD06519 的设计与评估:一种新型喜树碱类药物载体用于抗体偶联药物。
Mol Cancer Ther. 2024 May 2;23(5):606-618. doi: 10.1158/1535-7163.MCT-23-0822.
9
Topoisomerase 1 facilitates nucleosome reassembly at stress genes during recovery.拓扑异构酶 1 在恢复过程中促进应激基因的核小体重组。
Nucleic Acids Res. 2023 Dec 11;51(22):12161-12173. doi: 10.1093/nar/gkad1066.
10
Narciclasine, a novel topoisomerase I inhibitor, exhibited potent anti-cancer activity against cancer cells.水仙环素,一种新型拓扑异构酶I抑制剂,对癌细胞表现出强大的抗癌活性。
Nat Prod Bioprospect. 2023 Aug 29;13(1):27. doi: 10.1007/s13659-023-00392-1.